Welby Inc.

Tokyo Stock Exchange 4438.T

Welby Inc. EBITDA Margin for the year ending December 31, 2023: -75.65%

Welby Inc. EBITDA Margin is -75.65% for the year ending December 31, 2023, a -2,073.44% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Welby Inc. EBITDA Margin for the year ending December 31, 2022 was 3.83%, a 134.20% change year over year.
Welby Inc. EBITDA Margin for the year ending December 31, 2021 was -11.21%, a 68.66% change year over year.
Welby Inc. EBITDA Margin for the year ending December 31, 2020 was -35.77%, a -8,336.13% change year over year.
Welby Inc. EBITDA Margin for the year ending December 31, 2019 was 0.43%, a -97.80% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Tokyo Stock Exchange: 4438.T

Welby Inc.

CEO	Mr. Takeru Hiki
IPO Date	April 1, 2019
Location	Japan
Headquarters	Nomura Real Estate Nihonbashihoncho Bldg
Employees	53
Sector	Healthcare
Industries Telehealth Biotechnology Dental Care Drugstores & Retail Pharmacies Medical Instruments Mental Health Pharmaceuticals Software-as-a-Service (SaaS)

Description

Welby Inc. provides digital health solutions that help patients to get medical care services. The company offers services in the areas of diabetes mellitus, lifestyle related disease, mental illness, autoimmune disease, neurological disease, rare disease, oncology, and pain. It also engages in the medical data survey business; and operates Welby My Carte platform. The company was incorporated in 2011 and is based in Tokyo, Japan.

Key trends

Past 5 years